About Michael H. Tirgan, MD
"Dr. Tirgan is the only physician in North America whose medical practice and research is dedicated solely to the treatment of keloid patients. For the past several years, Dr. Tirgan has provided medical care and keloid treatment to over 1,600 keloid patients, many of whom traveled to New York from far away places."
Clinical Trials at Michael H. Tirgan, MD
During the past decade, Michael H. Tirgan, MD conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Michael H. Tirgan, MD
According to Clinical.Site data, the most researched conditions in "Michael H. Tirgan, MD" are
"Keloid" (7 trials) and "Keloids" (1 trials). Many other conditions were trialed in "Michael H. Tirgan, MD" in a lesser frequency.
Clinical Trials Intervention Types at Michael H. Tirgan, MD
Most popular intervention types in "Michael H. Tirgan, MD" are "Biological" (1 trials), "Drug" (1 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "History of Radiation Therapy" (1 trials), "History of prior Surgery" (1 trials), "Sorafenib" (1 trials) and "bevacizumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Michael H. Tirgan, MD
The vast majority of trials in "Michael H. Tirgan, MD" are
8 trials for "All" genders.
Clinical Trials Status at Michael H. Tirgan, MD
Currently, there are NaN active trials in "Michael H. Tirgan, MD".
undefined are not yet recruiting,
2 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Michael H. Tirgan, MD,
undefined suspended trials,
and 4 terminated clinical trials to date.
Out of the total trials that were conducted in Michael H. Tirgan, MD, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".